| Style | Citing Format |
|---|---|
| MLA | Dorafshan S, et al.. "Clinicopathological Significance of Plac1 Expression in Patients With Bladder Urothelial Carcinoma." International Journal of Molecular and Cellular Medicine, vol. 15, no. 2, 2026, pp. 1434-1448. |
| APA | Dorafshan S, Madjd Z, Zanjani L S, Rahimi M, Safaei S, Borumandnia N, Zarnani A H, Ghods R (2026). Clinicopathological Significance of Plac1 Expression in Patients With Bladder Urothelial Carcinoma. International Journal of Molecular and Cellular Medicine, 15(2), 1434-1448. |
| Chicago | Dorafshan S, Madjd Z, Zanjani L S, Rahimi M, Safaei S, Borumandnia N, Zarnani A H, Ghods R. "Clinicopathological Significance of Plac1 Expression in Patients With Bladder Urothelial Carcinoma." International Journal of Molecular and Cellular Medicine 15, no. 2 (2026): 1434-1448. |
| Harvard | Dorafshan S et al. (2026) 'Clinicopathological Significance of Plac1 Expression in Patients With Bladder Urothelial Carcinoma', International Journal of Molecular and Cellular Medicine, 15(2), pp. 1434-1448. |
| Vancouver | Dorafshan S, Madjd Z, Zanjani L S, Rahimi M, Safaei S, Borumandnia N, et al.. Clinicopathological Significance of Plac1 Expression in Patients With Bladder Urothelial Carcinoma. International Journal of Molecular and Cellular Medicine. 2026;15(2):1434-1448. |
| BibTex | @article{ author = {Dorafshan S and Madjd Z and Zanjani L S and Rahimi M and Safaei S and Borumandnia N and Zarnani A H and Ghods R}, title = {Clinicopathological Significance of Plac1 Expression in Patients With Bladder Urothelial Carcinoma}, journal = {International Journal of Molecular and Cellular Medicine}, volume = {15}, number = {2}, pages = {1434-1448}, year = {2026} } |
| RIS | TY - JOUR AU - Dorafshan S AU - Madjd Z AU - Zanjani L S AU - Rahimi M AU - Safaei S AU - Borumandnia N AU - Zarnani A H AU - Ghods R TI - Clinicopathological Significance of Plac1 Expression in Patients With Bladder Urothelial Carcinoma JO - International Journal of Molecular and Cellular Medicine VL - 15 IS - 2 SP - 1434 EP - 1448 PY - 2026 ER - |